Tacrolimus Capsule Suppliers & Bulk Manufacturers
Available Forms: Capsule
Available Strengths: 0.5mg, 1mg, 5mg
Reference Brands: Prograf® (US, EU), Advagraf® (extended-release form, EU), Astagraf XL® (extended-release, US)
Category:
Nephrology
Tacrolimus Capsules are immunosuppressive medications used in nephrology to prevent organ rejection in kidney transplant patients.
Tacrolimus Capsule is available in Capsule
and strengths such as 0.5mg, 1mg, 5mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tacrolimus Capsule is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tacrolimus Capsule can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tacrolimus Capsules are an essential immunosuppressant used primarily in nephrology for the prevention of organ rejection in kidney transplant patients. As a calcineurin inhibitor, Tacrolimus helps suppress immune responses, improving graft survival rates. Widely marketed under brand names like Prograf® (US, EU), Advagraf® (EU), and Astagraf XL® (US), these capsules are available in strengths of 0.5 mg, 1 mg, and 5 mg. Tacrolimus is a critical component in post-transplant therapy protocols. Ideal for Pharma B2B buyers, exporters, and distributors, Tacrolimus Capsules offer consistent demand across global renal care markets. Partner with reliable manufacturers for high-quality, GMP-certified supply.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing